Baylor Genetics Unveils RNA Sequencing Advances for Rare Disease Diagnosis at 2025 AGBT Precision Health Meeting

Baylor Genetics is set to showcase groundbreaking innovations in RNA sequencing for rare disease diagnosis at the 2025 Advances in Genome Biology and Technology (AGBT) Precision Health Meeting, according to…

Continue Reading Baylor Genetics Unveils RNA Sequencing Advances for Rare Disease Diagnosis at 2025 AGBT Precision Health Meeting

FDA Reviewing First-Ever Treatment for Barth Syndrome, Possibly Marking Major Milestone for Rare Disease Community

The U.S. Food and Drug Administration (FDA) is reviewing the first medication specifically developed for Barth syndrome, a rare and life-threatening genetic disorder. As reported by STAT, this medication could…

Continue Reading FDA Reviewing First-Ever Treatment for Barth Syndrome, Possibly Marking Major Milestone for Rare Disease Community